About Columbia Labs

Columbia Laboratories (Nasdaq:CBRX) has a rich history in drug development. We offer broad formulation, development, manufacturing and analytical capabilities through our wholly-owned subsidiary, Molecular Profiles Ltd. Learn More

In the News

Molecular Profiles Ltd.

Founded in 1997 to provide high-end pharmaceutical analysis, Molecular Profiles is a world-class research provider successfully servicing both emerging and multi-national pharmaceutical companies and supporting the development of novel drugs.

 

Partners & Products

We commercialize our products through strategic alliances with partners including:

   
   

Our stringent criteria ensure our partners have the market knowledge and sales force capacity to sell our products in the specific markets they will address.

Current Events

29 April 2014: CBRX Q1 2014 Conference Call - 8:30am EDT - click here 

05 Mar 2014: CBRX Q4 and YE 2013 Conference Call - Archive

CBRX Presentation

Download Columbia's investor presentation PDF